Skip to Content

Stress, Depressive Symptoms Up With Increasing COVID-19 Deaths

MONDAY, Sept. 21, 2020 -- Acute stress and depressive symptoms have increased as COVID-19 deaths increased across the United States, with COVID-19-related media exposure and secondary stressors associated with these symptoms, according to a study published online Sept. 18 in Science Advances.

E. Alison Holman, Ph.D., from the Sue & Bill Gross School of Nursing at the University of California in Irvine, and colleagues assessed acute stress, depressive symptoms, and direct, community, and media-based exposures to COVID-19 in three consecutive representative samples across three 10-day periods between March 18 and April 18, 2020 (6,514 individuals).

The researchers found that as COVID-19 deaths increased across the United States, there were increases in acute stress and depressive symptoms. Associations with acute stress and depressive symptoms were seen for preexisting mental and physical health diagnoses, daily hours of COVID-19-related media exposure, exposure to conflicting COVID-19 information in the media, and secondary stressors, including job and wage loss and shortage of necessities.

"It's critical that we prioritize providing resources to communities most in need of support right now -- the unemployed, poor or chronically ill people, and young people," Holman said in a statement. "We also encourage the public to limit exposure to media as an important public health intervention. It can prevent mental and physical health symptoms and promote resilience."

Abstract/Full Text

© 2020 HealthDay. All rights reserved.

Posted: September 2020

Read this next

Findings Conflicted for Benefit of Tocilizumab in COVID-19

FRIDAY, Oct. 23, 2020 -- Tocilizumab may be beneficial for adults with COVID-19 admitted to the intensive care unit (ICU), although other findings are conflicting, according to...

Survival From COVID-19 High in Patients With Psoriasis

FRIDAY, Oct. 23, 2020 -- For patients with psoriasis, survival from COVID-19 is high, with increased hospitalization risk in association with nonbiologic systemic therapy versus...

Convalescent Plasma Has Limited Benefit for Moderate COVID-19

FRIDAY, Oct. 23, 2020 -- For patients with moderate COVID-19, convalescent plasma does not reduce progression to severe COVID-19 or mortality, according to a study published...